沃生物制药 VOR
$19.88 +$1.22 (+6.54%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $20.20 +1.61%
开盘$19.11
昨收$18.66
当日区间$18.62 – $20.00
成交量555.5K
市值$1.22B
市盈率（TTM）0.1
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$0.00
营业利润-$58.44M-107.9% YoY
净利润-$86.73M+89.3% YoY
摊薄每股收益-$1.45+98.8% YoY
自由现金流-$32.77M+39.2% YoY
经营现金流-$32.75M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
资产收益率402.6%
流动比率13.50
负债/资产比率127.6%
现金及投资$481.55M
总负债$2.44M
净现金（净负债）$479.11M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $58.44M | $47.85M | $35.16M | $371.64M | $35.96M |
| 销售及管理费用 | $23.91M | $21.93M | $17.57M | $50.11M | $16.77M |
| -管理费用 | $23.91M | $21.93M | $17.57M | $50.11M | $16.77M |
| 研发费用 | $34.53M | $25.92M | $17.60M | $321.53M | $19.19M |
| 营业利润 | -$58.44M | -$47.85M | -$35.16M | -$371.64M | -$35.96M |
| 非经营性利息净收入（支出） | $4.61M | $4.34M | $3.94M | $5.87M | $2.80M |
| 非经营性利息收入 | $4.61M | $4.34M | $3.94M | $5.87M | $2.80M |
| 其他收入（支出） | -$32.89M | -$19.30M | -$188.36M | -$330.21M | $1.76B |
| 证券出售收益 | -$32.89M | -$19.30M | -$188.36M | -$334.36M | $1.76B |
| 税前利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 净利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 持续经营利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 归属母公司净利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 归属普通股股东净利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 基本每股收益 | -$1.45 | -$1.16 | -$5.11 | -$70.50 | $44.50 |
| 摊薄每股收益 | -$1.45 | -$1.16 | -$5.11 | -$70.50 | $44.50 |
| 其他非经营性收入（支出） | – | – | – | $4.15M | $2,000.00 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $496.31M | $481.05M | $506.75M | $464.13M | $464.13M |
| 流动资产合计 | $490.52M | $475.11M | $500.78M | $458.11M | $458.11M |
| 现金及现金等价物与短期投资 | $481.55M | $466.13M | $491.53M | $455.21M | $455.21M |
| -现金及现金等价物 | $78.98M | $107.86M | $169.87M | $396.49M | $396.49M |
| -短期投资 | $402.57M | $358.27M | $321.65M | $58.72M | $58.72M |
| 预付资产 | $4.97M | $5.88M | $6.39M | $1.15M | $1.15M |
| 其他流动资产 | $4.01M | $3.10M | $2.86M | $1.75M | $1.75M |
| 非流动资产合计 | $5.79M | $5.95M | $5.97M | $6.02M | $6.02M |
| 固定资产净值 | $3.23M | $3.37M | $3.39M | $3.47M | $3.47M |
| -固定资产原值 | $3.36M | $3.46M | $3.45M | $3.49M | $3.49M |
| -累计折旧 | -$128,000.00 | -$90,000.00 | -$53,000.00 | -$25,000.00 | -$25,000.00 |
| 其他非流动资产 | $2.56M | $2.58M | $2.58M | $2.55M | $2.55M |
| 负债合计 | $633.49M | $681.25M | $657.17M | $628.44M | $628.44M |
| 流动负债合计 | $36.34M | $24.81M | $16.08M | $25.17M | $25.17M |
| 应付款 | $5.61M | $4.00M | $1.04M | $5.13M | $5.13M |
| -应付账款 | $5.61M | $4.00M | $1.04M | $5.13M | $5.13M |
| 一年内应计费用 | $23.58M | $15.76M | $11.80M | $16.14M | $16.14M |
| 短期债务及融资租赁负债 | $370,000.00 | $335,000.00 | $307,000.00 | $280,000.00 | $280,000.00 |
| -一年内到期融资租赁负债 | $370,000.00 | $335,000.00 | $307,000.00 | $280,000.00 | $280,000.00 |
| 其他流动负债 | $476,000.00 | – | $698,000.00 | $554,000.00 | $554,000.00 |
| 非流动负债合计 | $597.14M | $656.44M | $641.09M | $603.27M | $603.27M |
| 长期债务及融资租赁负债 | $2.44M | $2.54M | $2.63M | $2.72M | $2.72M |
| -长期融资租赁负债 | $2.44M | $2.54M | $2.63M | $2.72M | $2.72M |
| 衍生产品负债 | $594.70M | $653.89M | $638.46M | $600.55M | $600.55M |
| 股东权益合计 | -$137.17M | -$200.20M | -$150.42M | -$164.31M | -$164.31M |
| 股东权益 | -$137.17M | -$200.20M | -$150.42M | -$164.31M | -$164.31M |
| 股本 | $20,000.00 | $19,000.00 | $19,000.00 | $18,000.00 | $18,000.00 |
| -普通股 | $20,000.00 | $19,000.00 | $19,000.00 | $18,000.00 | $18,000.00 |
| -优先股 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| 资本公积 | $1.39B | $1.24B | $1.22B | $988.60M | $988.60M |
| 留存收益 | -$1.52B | -$1.44B | -$1.37B | -$1.15B | -$1.15B |
| 不影响留存收益的损益 | -$1.85M | -$922,000.00 | -$706,000.00 | $41,000.00 | $41,000.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$32.75M | -$25.38M | -$38.25M | -$142.71M | -$22.80M |
| 持续经营经营活动现金流净额 | -$32.75M | -$25.38M | -$38.25M | -$142.71M | -$22.80M |
| 持续经营净利润 | -$86.73M | -$62.81M | -$219.59M | -$695.98M | $1.72B |
| 持续经营损益 | $32.89M | – | – | $3.30M | -$2.09B |
| 折旧、折耗与摊销 | $39,000.00 | $36,000.00 | $28,000.00 | $2.89M | $23,000.00 |
| 其他非现金项目 | -$1.27M | -$188.25M | $188.47M | $518.03M | $334.50M |
| 营运资金变动 | $11.46M | $9.01M | -$15.54M | $10.21M | $3.16M |
| -预付资产变动 | $4,000.00 | $278,000.00 | -$6.36M | $1.68M | -$873,000.00 |
| -应付账款及应计费用变动 | $11.51M | $8.80M | -$9.10M | $10.93M | $6.21M |
| -其他流动资产变动 | $23,000.00 | -$7,000.00 | -$20,000.00 | $0.00 | -$2.11M |
| -其他流动负债变动 | -$70,000.00 | -$62,000.00 | -$61,000.00 | -$2.41M | -$59,000.00 |
| 投资活动现金流净额 | -$44.78M | -$36.53M | -$263.24M | -$48.80M | -$48.97M |
| 持续经营投资活动现金流净额 | -$44.78M | -$36.53M | -$263.24M | -$48.80M | -$48.97M |
| 固定资产购置及出售净额 | -$25,000.00 | -$120,000.00 | -$48,000.00 | -$142,000.00 | -$314,000.00 |
| 投资购置及出售净额 | -$44.76M | -$36.41M | -$263.19M | -$48.66M | -$48.66M |
| 筹资活动现金流 | $48.65M | -$106,000.00 | $74.87M | $503.81M | $307.80M |
| 持续经营筹资活动现金流净额 | $48.65M | -$106,000.00 | $74.87M | $503.81M | $307.80M |
| 普通股发行净额 | $48.40M | $0.00 | $75.00M | $328.21M | $307.95M |
| 股票期权行使所得 | $254,000.00 | $1,000.00 | -$2,000.00 | $176.93M | -$19,000.00 |
| 其他筹资费用净额 | $0.00 | -$107,000.00 | -$127,000.00 | -$1.33M | -$131,000.00 |
| 期末现金余额 | $79.15M | $108.02M | $170.04M | $396.65M | $396.65M |
| 现金净变动 | -$28.88M | -$62.02M | -$226.61M | $312.29M | $236.02M |
| 期初现金余额 | $108.02M | $170.04M | $396.65M | $84.36M | $160.63M |
| 自由现金流 | -$32.77M | -$25.50M | -$38.29M | -$143.65M | -$23.12M |
暂无评论——快来第一个聊聊 VOR。
登录后参与讨论。